Back to Resource Hub Case Study

Flexible RTSM Enables Mid-Study Switch to Direct-to-Patient Dispensation in Immunology Trial

Our Signant SmartSignals RTSM solution played an important role in a global pharmaceutical company’s multiregional, phase 2 immunology study by facilitating a mid-study switch to a central pharmacy direct-to-patient model, which replaced daily in-clinic dosing of the investigational product.

Our flexible RTSM was adapted to enable the transition to at-home visits and even provided specialized reporting to ensure both sites and home healthcare nurses gained visibility to what they needed to fulfill their responsibilities.

Download the case study for more details.

Similar posts

Looking for more insights? Explore related resources.

ARTICLE

A Novel Approach to Clinical Supply Chain Systems Integration

READ THE ARTICLE
WHITE PAPER

Direct to Patient RTSM Solution

READ THE PAPER
BLOG POST

Guide to Direct-to-Patient Clinical Supply Distribution

VISIT THE BLOG

Get notified on new marketing insights

Here mention the benefits of subscribing